Introduction Transforming care Investing in our people Accelerating possibilities Protecting the environment Creating value responsibly Appendix Indicator Description Response 2-8 Workers who are not employees Not currently disclosed Proxy Statement 2-9 Governance structure and composition Governance overview Performance Report, Our ESG strategy and priorities, Page 8 Performance Report, Creating value responsibly, Page 47 2-10 Nominating and selection of the highest governance body Proxy Statement Performance Report, Creating value responsibly, Page 47 2-11 Chair of the highest governance body Proxy Statement Performance Report, Our ESG strategy and priorities, Page 8 Role of the highest governance body in overseeing the Performance Report, Creating value responsibly, Page 47 2-12 management of impacts Performance Report Appendix, Stakeholder engagement, Page 58 Proxy Statement Form 10-K, Item 1. Business, Page 3 Proxy Statement 2-13 Delegation of responsibility for managing impacts Performance Report, Our ESG strategy and priorities, Page 8 Performance Report, Creating value responsibly, Page 47 2-14 Role of the highest governance body in sustainability reporting Proxy Statement Performance Report, Our ESG strategy and priorities, Page 8 2-15 Conflicts of interest Code of Conduct Proxy Statement Form 10-K, Item 1A. Risk Factors, Page 18 2-16 Communication of critical concerns Proxy Statement Code of Conduct 2-17 Collective knowledge of the highest governance body Proxy Statement 2-18 Evaluation of the performance of the highest governance body Proxy Statement 2-19 Remuneration policies Proxy Statement 2-20 Process to determine remuneration Proxy Statement 69 2022 Performance Report
Advancing Science for Life | Boston Scientific Page 68 Page 70